Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Cipla: $500m North American Sales Boost Possible In Five Years
Going Beyond Respiratory Key As Cipla Discloses Injectables Ambitions
Jan 19 2022
•
By
Dean Rudge
Cipla is aiming for significant growth in North America • Source: Alamy
More from Business
More from Generics Bulletin